Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Takeda at: AE.GBR-IRL@takeda.com.

IF Illuminate Paediatric Patient Multidisciplinary Team (MDT) Case Study Overview - (20 mins)

Watch the highlights from the second webinar from IF Illuminate, Takeda’s new medical educational series for UK healthcare professionals involved in the care of patients with intestinal failure (IF).

Our expert multi-disciplinary team includes Dr Elena Cernat (Leeds), Rachel Wood (Manchester), Amy Phipps (Bristol) & Hannah Littlechild (London) as they discussed the management of a paediatric IF patient using Revestive®▼(teduglutide).

Hear about the following topics:

  • Patient selection and onboarding for Revestive®
  • How Revestive® may lead to parenteral nutrition bag & nutrient requirement changes
  • Patient monitoring and managing expectations on therapy

C-APROM/GB/REV/0333 Date of preparation August 2025